Who owns Akari Therapeutics Plc?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
Institutional ownership of AKTX from SEC Form 13F filings across 7 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 7 institutions disclosed 49,972 shares of Akari Therapeutics Plc worth $371,284 — about 0% of shares outstanding; the largest disclosed holder is Cresset Asset Management, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
7
13F holders
$371,284
value, 2026 filers
0%
of shares outstanding (49,972 sh)
3
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of AKTX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Cresset Asset Management, LLC | 20,561 | $210,647 | 0.0% | 0% | 0.0% |
| 2 | JANE STREET GROUP, LLCNEW | 15,463 | $158,418 | 0.0% | 0% | new |
| 3 | HRT FINANCIAL LPNEW | 13,745 | $140 | 0.0% | 0% | new |
| 4 | IFP Advisors, Inc | 181 | $1,854 | 0.0% | 0% | 0.0% |
| 5 | SBI Securities Co., Ltd. | 14 | $143 | 0.0% | 0% | +180.0% |
| 6 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CONEW | 7 | $72 | 0.0% | 0% | new |
| 7 | Truvestments Capital LLC | 1 | $10 | 0.0% | 0% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.